Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 00:00 | 2026-01-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,103.48 | 292,148 | $322,380,731 | 91,896,978 | -0.3% |
| 2026-01-07 00:00 | 2026-01-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,085.01 | 1,390 | $1,508,165 | 92,189,126 | 0.0% |
| 2025-12-31 00:00 | 2025-12-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,085.04 | 3,593 | $3,898,531 | 92,190,516 | 0.0% |
| 2025-12-30 00:05 | 2025-12-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,085.17 | 2,629 | $2,852,920 | 92,194,109 | 0.0% |
| 2025-12-30 00:00 | 2025-12-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,085.04 | 240 | $260,409 | 92,196,738 | 0.0% |
| 2025-11-27 00:00 | 2025-11-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,109.30 | 15,632 | $17,340,624 | 92,196,978 | 0.0% |
| 2025-11-27 00:00 | 2025-11-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,095.35 | 147,061 | $161,082,634 | 92,212,610 | -0.2% |
| 2025-11-26 00:00 | 2025-11-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,068.52 | 142,307 | $152,058,089 | 92,359,671 | -0.2% |
| 2025-11-25 00:00 | 2025-11-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,058.66 | 105,326 | $111,504,097 | 92,501,978 | -0.1% |
| 2025-11-22 00:00 | 2025-11-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,051.66 | 37,148 | $39,067,118 | 92,607,304 | 0.0% |
| 2025-11-21 00:00 | 2025-11-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,051.17 | 167,526 | $176,098,707 | 92,644,452 | -0.2% |
| 2025-11-20 00:00 | 2025-11-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,034.78 | 60,213 | $62,306,967 | 92,811,978 | -0.1% |
| 2025-11-19 00:00 | 2025-11-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,030.68 | 9,886 | $10,189,270 | 92,872,191 | 0.0% |
| 2025-11-18 00:00 | 2025-11-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $425,738.48 | 178,295 | $75,907,041,792 | 92,882,077 | -0.2% |
| 2025-11-15 00:00 | 2025-11-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,030.26 | 46,606 | $48,016,097 | 93,060,372 | -0.1% |
| 2025-11-14 00:00 | 2025-11-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $1,011.18 | 305,000 | $308,411,212 | 93,106,978 | -0.3% |
| 2025-11-14 00:14 | 2025-11-13 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $1,010.50 | 1,000 | $1,010,500 | 2,840 | -26.0% |
| 2025-11-13 00:00 | 2025-11-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $986.64 | 283,131 | $279,347,690 | 93,411,978 | -0.3% |
| 2025-11-13 00:00 | 2025-11-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $972.52 | 16,869 | $16,405,396 | 93,695,109 | 0.0% |
| 2025-11-07 00:00 | 2025-11-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $951.56 | 40,432 | $38,473,442 | 93,711,978 | 0.0% |
| 2025-11-07 00:00 | 2025-11-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $933.26 | 179,042 | $167,092,110 | 93,752,410 | -0.2% |
| 2025-11-06 00:00 | 2025-11-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $910.72 | 526 | $479,038 | 93,931,452 | 0.0% |
| 2025-11-05 00:00 | 2025-11-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $888.83 | 300,000 | $266,648,910 | 93,931,978 | -0.3% |
| 2025-11-04 00:00 | 2025-10-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $863.35 | 301,342 | $260,165,032 | 94,231,978 | -0.3% |
| 2025-10-14 23:00 | 2025-10-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $863.24 | 3,658 | $3,157,722 | 94,533,320 | 0.0% |
| 2025-10-10 23:00 | 2025-10-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $852.49 | 10,602 | $9,038,056 | 94,536,978 | 0.0% |
| 2025-10-09 23:00 | 2025-10-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $850.27 | 101,420 | $86,234,870 | 94,547,580 | -0.1% |
| 2025-10-08 23:00 | 2025-10-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $848.01 | 26,795 | $22,722,401 | 94,649,000 | 0.0% |
| 2025-10-07 23:00 | 2025-10-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $850.22 | 161,183 | $137,041,655 | 94,675,795 | -0.2% |
| 2025-10-06 23:00 | 2025-10-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $837.93 | 192,404 | $161,220,410 | 94,836,978 | -0.2% |
| 2025-10-03 23:00 | 2025-10-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $821.55 | 112,596 | $92,503,356 | 95,029,382 | -0.1% |
| 2025-10-02 23:56 | 2025-10-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $821.47 | 215,822 | $177,290,457 | 95,141,978 | -0.2% |
| 2025-10-02 23:55 | 2025-10-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $794.15 | 135,193 | $107,363,021 | 95,357,800 | -0.1% |
| 2025-10-01 23:00 | 2025-09-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $763.39 | 113,694 | $86,793,272 | 95,492,993 | -0.1% |
| 2025-09-22 23:00 | 2025-09-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $763.10 | 23,665 | $18,058,643 | 95,606,687 | 0.0% |
| 2025-09-19 23:00 | 2025-09-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $764.65 | 106,626 | $81,531,955 | 95,630,352 | -0.1% |
| 2025-08-28 23:14 | 2025-08-28 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $734.93 | 1,000 | $734,930 | 3,840 | -20.7% |
| 2025-08-15 23:13 | 2025-08-15 | LLY | ELI LILLY & Co | Montarce Lucas | Officer; EVP & CFO | Pharmaceutical Preparations | BUY | $691.79 | 715 | $494,627 | 14,685 | +5.1% |
| 2025-08-14 23:12 | 2025-08-13 | LLY | ELI LILLY & Co | Alvarez Ralph | Director | Pharmaceutical Preparations | BUY | $660.25 | 758 | $500,473 | 758 | +100.0% |
| 2025-08-13 23:15 | 2025-08-13 | LLY | ELI LILLY & Co | Van Naarden Jacob | Officer; EVP & Pres., Lilly Oncology | Pharmaceutical Preparations | BUY | $647.36 | 1,000 | $647,360 | 20,562 | +5.1% |
| 2025-08-12 23:16 | 2025-08-11 | LLY | ELI LILLY & Co | Yuffa Ilya | Officer; EVP&Pres, LLY USA&Global Capab | Pharmaceutical Preparations | SALE | $627.01 | 1,250 | $783,763 | 26,260 | -4.5% |
| 2025-08-12 23:20 | 2025-08-12 | LLY | ELI LILLY & Co | Skovronsky Daniel | Officer; EVP, CSO & Pres. LRL & LLY Imm | Pharmaceutical Preparations | BUY | $634.41 | 1,000 | $634,405 | 137,660 | +0.7% |
| 2025-08-12 23:23 | 2025-08-12 | LLY | ELI LILLY & Co | Ricks David A | Director, Officer; President, Chair, and CEO | Pharmaceutical Preparations | BUY | $644.77 | 1,632 | $1,052,263 | 546,601 | +0.3% |
| 2025-08-12 23:17 | 2025-08-12 | LLY | ELI LILLY & Co | Fyrwald J Erik | Director | Pharmaceutical Preparations | BUY | $642.33 | 1,565 | $1,005,242 | 74,578 | +2.1% |
| 2025-08-12 23:19 | 2025-08-12 | LLY | ELI LILLY & Co | Sulzberger Gabrielle | Director | Pharmaceutical Preparations | BUY | $641.18 | 117 | $75,018 | 2,703 | +4.5% |
| 2025-08-08 23:20 | 2025-08-08 | LLY | ELI LILLY & Co | JACKSON JAMERE | Director | Pharmaceutical Preparations | BUY | $639.56 | 200 | $127,913 | 9,402 | +2.2% |
| 2025-07-25 23:00 | 2025-07-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $805.07 | 280,000 | $225,419,264 | 95,736,978 | -0.3% |
| 2025-05-27 23:13 | 2025-05-27 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $716.41 | 1,000 | $716,410 | 4,840 | -17.1% |
| 2025-05-15 23:17 | 2025-05-14 | LLY | ELI LILLY & Co | Yuffa Ilya | Officer; EVP & President, LLY Int'l | Pharmaceutical Preparations | SALE | $749.24 | 1,250 | $936,550 | 27,510 | -4.3% |
| 2025-03-13 23:17 | 2025-03-13 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $818.24 | 1,000 | $818,240 | 5,840 | -14.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.